• norsk
    • English
  • norsk 
    • norsk
    • English
  • Logg inn
Vis innførsel 
  •   Hjem
  • Faculty of Medicine
  • Department of Clinical Science
  • Department of Clinical Science
  • Vis innførsel
  •   Hjem
  • Faculty of Medicine
  • Department of Clinical Science
  • Department of Clinical Science
  • Vis innførsel
JavaScript is disabled for your browser. Some features of this site may not work without it.

Plasma tumour necrosis factor correlates with mRNA expression of tumour necrosis factor and mitochondrial transcription factors in skeletal muscle in patients with chronic heart failure treated with cardiac resynchronization therapy: potential role in myopathy

Larsen, Alf Inge; Valborgland, Torstein; Ogne, Christer; Lindal, Sigurd; Halvorsen, Bente; Munk, Peter Scott; Kvaløy, Jan Terje; Aukrust, Pål; Yndestad, Arne
Peer reviewed, Journal article
Accepted version
Thumbnail
Åpne
Accepted version (135.1Kb)
Permanent lenke
https://hdl.handle.net/1956/22195
Utgivelsesdato
2019
Metadata
Vis full innførsel
Samlinger
  • Department of Clinical Science [1695]
Originalversjon
https://doi.org/10.1177/2047487319855796
Sammendrag
Chronic heart failure (CHF) is characterized by inflammation and skeletal muscle myopathy, including impaired fibre type distribution and reduced capillary density, reduced cytochrome oxidase activity and reduced mitochondrial density. The myopathy is associated with activation of the interleukin-6–C-reactive protein pathway and the prototypical inflammatory cytokine tumour necrosis factor (TNF) with alterations in the mRNA expression of enzymes essential in mitochondrial biogenesis. Central in this process are peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), nicotinamide phosphoribosyltransferase (NAMPT), nicotinamide adenine dinucleotide and mitochondrial transcription factor (TFAM). The covariance over time between plasma levels of TNF and skeletal muscle mRNA expression of this pro-inflammatory cytokine, and the correlation between TNF and mRNA expression of enzymes essential in mitochondrial biogenesis and skeletal muscle pathology has not previously been evaluated in patients with CHF on stable medical treatment. The methods have been described previously1 and are briefly presented here.
Utgiver
Sage
Tidsskrift
European Journal of Preventive Cardiology
Opphavsrett
Copyright The European Society of Cardiology 2019

Kontakt oss | Gi tilbakemelding

Personvernerklæring
DSpace software copyright © 2002-2019  DuraSpace

Levert av  Unit
 

 

Bla i

Hele arkivetDelarkiv og samlingerUtgivelsesdatoForfattereTitlerEmneordDokumenttyperTidsskrifterDenne samlingenUtgivelsesdatoForfattereTitlerEmneordDokumenttyperTidsskrifter

Min side

Logg inn

Statistikk

Besøksstatistikk

Kontakt oss | Gi tilbakemelding

Personvernerklæring
DSpace software copyright © 2002-2019  DuraSpace

Levert av  Unit